Background NHS RightCare is an NHS England programme describing itself as 'a proven approach that delivers better patient outcomes'. It identifies opportunities for savings and quality improvements, comparing each Clinical Commissioning Group (CCG) with the 'Best 5' of a fixed set of 'Similar 10' CCGs chosen using equally weighted demographic and deprivation indicators. This article tests whether these indicators are sufficient and equal weighting is appropriate, and evaluates significance.
Introduction
NHS RightCare is an NHS England programme which describes itself as 'a proven approach that delivers better patient outcomes and frees up funds for further innovation. ' 1 It is mentioned in almost all Sustainability and Transformation Plans, which aim to implement the Five Year Forward View, intended to reduce annual NHS spending by £22 bn.
As Liverpool Clinical Commissioning Group (CCG) states, 'The NHS Five Year Forward View modelled the need for the health system to generate £22 bn of efficiencies by 2020/21. The NHS RightCare programme is a critical part of NHS England's approach to driving allocative efficiency in order to meet this need.' 2 In the 'Next Steps on the Five Year Forward View' 3 NHS England promotes RightCare, and various CCG Operational Plans cite savings based on RightCare. [4] [5] [6] However, recent press articles have highlighted the role of RightCare in unjustified proposals to cut hip and knee replacement surgery. 7, 8 This article examines the methodology by which RightCare pinpoints opportunities for savings and quality improvements. Together with Public Health England, RightCare has produced Commissioning for Value packs tailored to each CCG. 9 For example, Cancer and Tumours packs highlight (on page 97) significant annual opportunities to avert lung cancer mortality <75 years, with 156 lives to be saved in Cheshire and Merseyside, including 80 lives per year for Liverpool CCG. [10] [11] [12] [13] [14] Across England, the claims total 1842 avoidable lung cancer deaths per year.
No new preventative, diagnostic, or therapeutic techniques are mentioned. The opportunities arise from data analysis, without reference to the CCG's actual ability to address them. For example, mortality can reflect the underlying incidence, largely outside the CCG's influence. Commissioners wishing to reduce cancer or heart disease can promote smoking cessation but can they control stress, deprivation, air pollution or undiagnosed disease, either immediately or in a few years?
For each CCG, RightCare specifies a fixed group of 10 'similar' CCGs, identified by demographic characteristics (including deprivation). Whether the health outcome is colorectal cancer mortality or breastfeeding initiation, the CCG is evaluated against the same 'Similar 10'. For each specific outcome, the 'Best 5' of the 'Similar 10' are identified by their performance for that outcome. If lower outcome values are better, the Best 5 are those with the lowest five values and RightCare reports a significant opportunity when a 95% confidence interval for the CCG value exceeds the average for the Best 5.
The method uses 12 demographic indicators 15 : Index of Multiple Deprivation (IMD), IMD Health (the Health domain of IMD), total population, population under 5 years, 5-14 years, 15-24 years, over 75 years, ADSONS (Ratio of registered population to Office for National Statistics estimates), population density, population density slope, population percentage Black and population percentage Asian.
The Similar 10 for a given CCG are those closest in demography, as follows. Each indicator is standardized by subtracting its median and dividing by the difference between its 90th and 10th percentiles. The distance between two CCGs is defined as the sum of the squares of the differences between their corresponding standardized indicators. For each CCG, the Similar 10 are its 10 nearest neighbours, using this measure of distance. The method implicitly assumes that:
• These 12 indicators are the key factors influencing all the health outcomes.
• All the standardized indicators have similar impacts, independent of the health outcome. 
Methods
To check whether RightCare would find a 'significant opportunity' if a CCG were indistinguisable from its comparators, 100 000 rows were simulated from 11 independent identical Poisson variables X 1 , X 2 , … X 11 (cancers follow a Poisson distribution). In each row, the exact lower 97.5% confidence limit of the observed x 1 was compared with the average of the five lowest of x 2 … x 11 . Corresponding simulations using binomial variables were carried out with the Wilson score test.
Linear models for breast, colorectal, and lung cancer mortality <75 years were constructed using public data in the May 2016 Focus Pack on Cancer and Tumours, as the Primary Care Mortality Database is not publicly accessible. 16 For mortality and incidence of these cancers, the Pack includes directly age-standardized rates (DSR) per 100 000 European Standard Population for pooled data from 2011 to 2013.
Raw demographic and deprivation data was taken from the RightCare Similar 10 Explorer tool. 15 This predates the amalgamation of three CCGs to form Newcastle Gateshead as one of 209 CCGs in the Cancer and Tumours dataset. Population and deprivation data for Newcastle Gateshead is available from 2015, 17, 18 and other covariates were estimated by population weighted averages from the three former CCGs. The resulting raw data along with incidence rates were standardized as in the Explorer tool.
Three linear models for DSR were considered for each cancer site. M1, like RightCare, requires all 12 standardized demographic (and deprivation) indicators to have identical impacts. M2 allows the 12 to act independently. M3 chooses a preferred model for each cancer, using only the most relevant covariates. For each cancer, M3 is obtained by selection to minimize the BIC criterion 19 among all linear models containing any of the 12 standardized demographic indicators or incidence. It is the preferred linear model to predict mortality DSR for that cancer using standardized demography or incidence.
The peers for a particular health outcome and CCG are the 10 CCGs whose predicted values, using the preferred model, are closest to the predicted value for the CCG in question. If the model gives a good fit to the data overall, the CCG and its peers should behave similarly, and differences between the observed values for the CCG and a peer average may indicate an actual problem.
Observed values are considered significantly different if their corresponding 95% confidence intervals do not overlap. This requires confidence intervals for the average DSR of the Best 5, Similar 10, or more appropriate peers.
The data shows CIs for each DSR, which are normally calculated by Dobson's method. 20 
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where O is the total number of cases (here, cancer deaths), assumed to follow a Poisson distribution. Dobson's method uses the fact that DSR is a linear combination of Poisson variables. But so is the mean of the lowest five DSRs, whose variance will be 1/25 * Σ Var (DSR i ), summing over the five lowest DSRs, assumed here to be independent for the different CCGs. In this way, CIs can be obtained for the mean of the RightCare Best 5 or the lowest 5 peers.
Calculations were carried out with the open source software R. 21 
Results
If the hypothetical outcomes for the CCG and Similar 10 are identical independently distributed Poisson variables with means λ = 10 (likewise 50, 200 or 500), RightCare 'significant opportunities' for lower outcomes arise over 12% of the time, even though the fictitious CCG and Similar 10 are indistinguishable. For identical independent binomial variables with N = 100 and P = 0.05, RightCare 'significant opportunities' for lower outcomes arise 21% of the time, or 17% if P = 0.1. With N = 1000, the corresponding rates are 15 and 14%.
Model M1 fits the data poorly, giving adjusted R 2 = 0.0513, −0.0047 and 0.1402, for breast, colorectal and lung cancer mortality <75 years, respectively.
Scatter plots (Fig. 1) of DSR against the predicted values show wide dispersion, but the Similar 10 are fairly close to the CCG in their predictions from this model. M2 gives adjusted R 2 = 0.066, 0.2372 and 0.7715, for breast, colorectal and lung, respectively. This model improves the fit, but some component effects are insignificant.
The preferred models M3 have formulas:
Breast: DSR~pop75p Colorectal: DSR~IMDhealth + pcasian Lung: DSR~inci + IMDhealth + pcasian
The incidence term is selected only in the lung model. Table 1 shows fitted coefficients and overall fit of M3 for each cancer. All the terms are highly significant. Bradford City is the only outlier for colorectal and lung, with DSR below prediction. Different models are selected for different cancers, and the fitted coefficients differ for the various covariates. Only the lung model gives a convincing fit, with incidence the strongest predictor. Fig. 2 shows peers chosen to minimize the distance between their M3 predicted values and that of the CCG. As M3 improves the overall fit, the observed values are closer than in Fig. 1 , particularly for the lung. RightCare reports a significant opportunity if the lower CI for the CCG DSR exceeds the observed mean DSR for the Best 5. However, mean DSR is a random variable whose CI can be estimated (see Methods). The Liverpool DSR for lung cancer mortality is reported in the data as 57.8 with 95% CI (52.8, 63.2). The mean DSR for the lowest five peers chosen from the selected lung model is 51.9 (48.8, 55.0). As the two CIs overlap, DSR is not significantly higher than the mean DSR of the lowest five peers.
There is no CCG within Cheshire & Merseyside or Greater Manchester for which lung cancer mortality <75 years is significantly higher than the mean of its lowest five peers, as identified with M3.
RightCare calculates the difference between DSR for the CCG and the mean DSR for its Best 5 comparators (for that cancer). The RightCare annual opportunity is this difference, multiplied by population/100,000. Nationally, RightCare finds 80 CCGs with significant opportunities to avert lung cancer deaths <75 years, totalling 1842 annual deaths. However, only eight CCGs (seven of which are identified by RightCare) with a total of 168 annual deaths, have DSRs significantly higher than the mean of their lowest five peers chosen using M3.
The Focus packs (page 13) show lung cancer 'Pathways on a page', comparing the CCG with its Similar 10. Again, these ignore the variation in average outcomes of comparators. For Knowsley, the corrected estimates from RightCare and the lung model lack significant elevation, as shown in Fig. 4 .
A focus on mortality can miss patterns revealed by trends in its relationships with incidence and survival. 22 The CancerData dashboard 23 shows incidence and survival for lung cancers in Liverpool CCG compared with the rest of Cheshire and Merseyside, and the national rates. Liverpool has persistently high incidence, which drives mortality despite increasingly effective treatment shown by 1-year survival. A recent Office for National Statistics bulletin 24 shows survival rates for adults aged 15-99 by CCG and cancer. 
Discussion
Main finding of this study RightCare chooses comparators using 12 standardized indicators, given equal weight regardless of the health outcome. However, for each outcome many indicators may be irrelevant, skewing the choice of comparators. Equal weighting corresponds (roughly) to the simplest model M1, which fits the cancer data poorly. As breast cancer shows, these indicators may be unable to predict mortality. Rates for lung cancer mortality <75 years can be predicted by incidence, IMD health deprivation, and Asian population percentage. Brighton, Bristol, and Sheffield have DSR (35, 38, 37.8) After choosing inappropriate comparators, RightCare overestimates significance by treating their average observed values as fixed, when they are random variables. Simulation shows that the RightCare interpretation of 'significant opportunity' is flawed, producing 12% Type I errors for identically distributed Poisson data, and 14−21% errors for various identically distributed binomial data.
RightCare interprets dissimilar outcomes as opportunities for improvement. Such outcomes could signify problems if a model which fits the overall data had predicted them to be close. Such conclusions are invalid if the model has poor fit. When predictions from a good model differ widely, different outcomes may confirm what we already knew, for example that Liverpool is not Brighton.
What is already known on this topic
PubMed lists four articles with keyword RightCare. [25] [26] [27] [28] The first three, from the US, do not mention the NHS or any of the issues above. The fourth refers to the NHS, but not to CCGs, Similar 10 or Best 5. Given the pressure for CCGs to adopt NHS RightCare, the lack of any peer-reviewed evaluation of its methods is striking.
Studies of patient surveys 29, 30 consider comparing health organizations by values which are themselves variable. Comparisons are unreliable if apparent variation between organizations is badly affected by variation at individual organizations. In the same spirit, when considering whether DSR can distinguish between CCGs, define the reliability r CCG = σ RightCare is based on the opposite view.
What this study adds
This appears to be the first attempt to evaluate NHS RightCare's approach to comparator groups and statistical significance, using publicly available data on cancer mortality and incidence.
Limitations of this study
The modelling was confined to three cancer mortality sites, and data quality could be an issue for other outcomes. Only linear models were fitted, using only the 12 demographic/ deprivation covariates and incidence rates, but other factors may be relevant.
Air pollution is a known cause of lung cancer, according to the IARC. 35 Public Health England analyzed variation across local authorities, estimating the number of deaths from respiratory disease attributable to air pollution using data from 2010. 36 For England, there were 25 002 estimated attributable deaths (age 25+), with 264 749 life-years lost. For Liverpool, the estimates were 239 deaths and 2440 lifeyears lost. Air pollution, like other environmental problems, could be controlled but is beyond the CCG's influence, and is not modelled here or mentioned in the RightCare packs.
Conclusion
There is no reason to expect that a CCG could match the average performance of the Best 5 of a fixed group of 10 CCGs, which may be highly dissimilar for the covariates which actually predict the chosen outcome. These factors may be beyond the CCG's influence.
One size does not fit all health outcomes. RightCare promises illusory savings based on an inappropriate fixed comparator group and faulty statistics.
Until public health statisticians with access to the data examine its quality and the methodology, claims by NHS RightCare to be 'a proven approach' are unsubstantiated. If RightCare is used to justify savings in NHS budgets, it is acting as a cover for cuts.
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